Generics 4

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Mirabegron manufacturers

4 products found

Filters

Filters

Filters , active

Country of origin : China

Clear all

4 products found

mirabegron

Tablets, extended release (ER) 25 mg, 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Manufacturer #31064

Established in 1970, this Chinese manufacturer specializes in the research, development, production, and sales of a wide range of pharmaceutical products. As a CTD dossier owner and manufacturer, it ensures compliance with international quality standards. The company operates advanced production lines across four industrial parks, covering approximately 1,333,400 square meters, and employs nearly 5,000 individuals, including over 2,000 professional and technical personnel. Its diverse product portfolio includes anesthetic agents, psychotropic medicines, nonsteroidal anti-inflammatory drugs, cardiovascular system medicines, antibiotics, and antiviral medicines. As a CTD dossier owner and manufacturer, its products are distributed across multiple countries worldwide. The manufacturer holds GMP certifications from international regulatory authorities, including the U.S. FDA and the Philippines FDA, ensuring adherence to stringent global quality standards

Manufacturer usually replies in 5 days

mirabegron

Tablets, extended release (ER) 25 mg, 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
FDA, South Africa
Manufacturer #25278

Founded in 2006, the Manufacturer is recognized as a CTD dossier owner and manufacturer specializing in biopharmaceuticals and healthcare. This GMP manufacturer operates advanced R&D centers and cGMP manufacturing facilities. As a CTD dossier owner and manufacturer, it offers a wide range of pharmaceutical and biotechnological products, serving major markets globally including the US, EU, and China. With rigorous GMP approvals, this CTD dossier owner and manufacturer continues to innovate and expand in the healthcare sector.

mirabegron

Tablets, sustained release (SR) 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Manufacturer #18656

Want to see all 4 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Mirabegron

Mirabegron treats overactive bladder. In this condition, the patient’s bladder muscles contract uncontrollably. This leads to frequent urination, urgent need to urinate, and inability to control urination. It can be used as a standalone therapy or in combination with Solifenacin. It has properties similar to antimuscarinic medication like Solifenacin. Its actions activate β3 adrenergic receptor in the bladder, leading to its relaxation. Mirabegron is sold under the brand name Myrbetriq among others. Astellas Pharma Inc. received the First approval for selling in the USA and EU in 2012. In 2017, with more than three million prescriptions, it was in the top 200 most prescribed drugs in the USA.

Dosage Forms & Strengths

Mirabegron is sold as an extended-release tablet in 25mg and 50mg strengths. In the treatment of overactive Bladder, as a Monotherapy, with symptoms of urge urinary incontinence, urgency, and urinary frequency, the dose is 25 mg, per day and it is typically effective within 2 months from the start of the therapy, the dosage can be increased to 50 mg a day dependent on individual efficacy and tolerance.

The price of Mirabegron

In the USA, the consumer has to pay an average retail price of $497.10 for 30 branded tablets. This medicine is much cheaper in the developing part of the world. In India, a supply of 30 tablets of 50mg of oral, tablets costs USD40.

How does Mirabegron work?

Mirabegron is a selective agonist for beta-3 adrenergic receptors with high potency. Upon activation of the beta-3 receptors, the detrusor smooth muscle relaxes to allow for a larger bladder capacity. At 200 mg doses (high), there is a potential to activate beta-1 and beta-2 adrenergic receptors. Its action results in the relaxation of the muscles around the bladder. This eventually results in increased bladder capacity thus reducing the urge or need to pee as frequently or as urgently.

Finding Mirabegron Manufacturers and Suppliers

The best way to find and gain access to Mirabegron manufacturers and Mirabegron suppliers is to make through Pipelinepharma's global B2B online marketplace for medicines and other pharmaceuticals. Normally, finding trusted manufacturers and supplies of specific drugs like Mirabegron can be a the time-consuming challenge, but with Pipelinepharma's simple search engine and network of proven partners, the whole process becomes a lot easier. All you need to do to get started is to make use of our integrated search engine and start looking for suppliers or manufacturers of Mirabegron to work with. You can fine-tune your search results using various filters too, letting you search for Mirabegron from specific countries.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible